Global Beta Blockers Market Report 2023: Forecast Market Size, Growth Rate And Key Drivers
31 Jul, 2023
The global beta blockers market size is expected to grow from $8.55 billion in 2022 to $9.16 billion in 2023 at a compound annual growth rate (CAGR) of 7.13%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global beta blockers market size is expected to reach $11.54 billion in 2027 at a CAGR of 5.9%.
Global Beta Blockers Market Key Driver
The rising prevalence of cardiovascular disorders is projected to drive the beta blocker industry forward. Cardiovascular diseases (CVDs) are conditions that affect the heart and blood arteries. The rise in the incidence of cardiovascular illnesses is primarily caused by bad diets, unhealthy lifestyles, a lack of exercise, tobacco use, and obesity, where beta blockers might help lower cardiovascular cases by exerting various favorable effects on the heart and blood vessels. As a result, increased incidences of cardiovascular disease are fueling the expansion of the beta blockers market.
Get a sample of the global beta blockers market reportGlobal Beta Blockers Market Segments
The global beta blockers market is segmented:
1) By Type: Non-selective Agents, Selective Agents
2) By Indication: Angina Pectoris, Heart Failure, High Blood Pressure, Other Indications
3) By Drugs: Betaxolol, Acebutolol, Esmolol, Other Drugs
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Cardiac Diseases, Hypertension, Glaucoma, Other Applications
6) By Geography: The regions covered in the beta blockers market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global beta blockers market.
Major Beta Blockers Industry Players
Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca PLC, Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bristol-Myers Squibb, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC., Abbott Laboratories, Eagle Pharmaceuticals Inc, Neon Healthcare Ltd, Midas Pharma GmbH, Global Calcium PVT LTD, AbbVie Inc.
Get the full global beta blockers market reportBeta Blockers Market Overview
Beta blockers also known as beta-adrenergic blocking agents, are a class of medications commonly used to treat various cardiovascular conditions by decreasing the activity of the heart. It is commonly prescribed for blood pressure control, angina, heart failure, and a few cardiac rhythm abnormalities.
Beta Blockers Global Market Report 2023 provides data on the global beta blockers market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The beta blockers market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.